Traditionally, the industry tends to favor Republicans.
Jay Hancock | Kaiser Health News
U.S. Senate to examine drug prices Tuesday
Kenneth Frazier, CEO of pharma giant Merck, is set to face senators Tuesday who say drug costs are “sky-high” and “out of control.”
Ending a ‘shadowy system of kickbacks’
The administration’s plan for drug rebates, announced Thursday, would end the pharmaceutical business as usual.
High-deductible health plans falling from grace in employer-based coverage
With workers harder to find and Obamacare’s tax on generous coverage postponed, employers are hitting pause on a feature of job-based medical insurance much hated by employees: the high-deductible health plan.
‘Massive confusion’ abounds for insurers as GOP wavers on Obamacare redo
Premiums for Obamacare plans sold by New Mexico Health Connections could rise as little as 7 percent next year, says Martin Hickey, the insurance company’s CEO. Or they might soar as much as 40 percent, he said. It all depends on what happens in Washington.
Employers fret job-based coverage vulnerable in GOP health overhaul
As President Donald Trump promises a replacement for the Affordable Care Act that will provide “insurance for everybody,” employers worry Republican attempts to redo other parts of the insurance market could harm their much larger one.